New York City-based Apogem Capital, a New York Life Insurance Company subsidiary, launched Apogem Private Equity Fund X LP in 2022 to invest in buyout and growth equity strategies across North America.
Apogem Capital is an alternative investment firm specializing in the middle market with approximately $41 billion in AUM. It was formed in 2022 after amalgamating the businesses of funds-of-funds manager PA Capital, lender Madison Capital, and co-investor GoldPoint Partners into one organization.
In total, the umbrella entity, which is a subsidiary of New York Life, has developed some 320 sponsor relationships and made approximately 2,700 investments. The private equity team manages about $20 billion in assets and invests across buyout, secondary, growth, turnaround and co-investment strategies. The firm has a long history of backing new funds and has committed $1.5 billion to 95 emerging managers. Apogem also has a “social advancement” strategy that targets managers from diverse backgrounds across Canada and the United States. The private credit team manages about $18 billion in assets spread across direct lending and junior debt strategies, while the real asset department has about $1 billion in AUM.
MS476
Assets Under Management: $41 billion
Connect with us to personally meet the founder of our company. He’ll give you an exclusive, first-hand demonstration of how you can identify Limited Partners for your next deal or fund.